| $350M | ||
| $172M | ||
| $127M | ||
| $109M | ||
| $107M | ||
| $100M |
Buys | $106,329 | 5 | 100 |
Sells | $0 | 0 | 0 |
| Coastlands Capital LP | 10 percent owner | 5 | $106,329 | 0 | $0 | $106,329 |
Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of alcohol use disorder. Beyond this flagship product, the company is also exploring drug candidates aimed at providing non-opioid pain relief and addressing a range of other medical conditions. Established in 2010, Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia.
Over the last 12 months, insiders at Adial Pharmaceuticals, Inc. have bought $106,329 and sold $0 worth of Adial Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Adial Pharmaceuticals, Inc. have bought $86,372 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Coastlands Capital LP (10 percent owner) — $106,329.
The last purchase of 1,233 shares for transaction amount of $3,391 was made by Coastlands Capital LP (10 percent owner) on 2026‑07‑16.
| 2026-07-16 | Coastlands Capital LP | 10 percent owner | 1,233 0.1299% | $2.75 | $3,391 | +54.48% | ||
| 2026-07-14 | Coastlands Capital LP | 10 percent owner | 2,000 0.2084% | $2.65 | $5,300 | +62.64% | ||
| 2026-07-10 | Coastlands Capital LP | 10 percent owner | 1,700 0.1721% | $2.70 | $4,590 | +51.44% | ||
| 2026-07-09 | Coastlands Capital LP | 10 percent owner | 10,053 1.0438% | $2.79 | $28,048 | +47.50% | ||
| 2026-06-29 | Coastlands Capital LP | 10 percent owner | 25,000 2.6152% | $2.60 | $65,000 | +46.72% | ||
| 2023-09-29 | Schuyler Kevin | director | 700 0.0566% | $2.74 | $1,918 | -50.18% | ||
| 2021-12-30 | Newman James W. Jr. | director | 25,000 0.1356% | $2.69 | $67,300 | -53.00% | ||
| 2021-11-30 | Stilley William B. III | Chief Executive Officer | 10,600 0.0565% | $2.75 | $29,179 | -51.80% | ||
| 2021-11-29 | Stilley William B. III | Chief Executive Officer | 10,000 0.0544% | $2.59 | $25,892 | -47.27% | ||
| 2021-11-26 | Newman James W. Jr. | director | 10,000 0.0538% | $2.85 | $28,500 | -52.28% | ||
| 2021-04-06 | Sale | Johnson Bankole A. | Chief Medical Officer | 150,000 0.8494% | $2.50 | $375,000 | +4.38% | |
| 2020-08-20 | Sale | Johnson Bankole A. | Chief Medical Officer | 350,000 2.0553% | $1.21 | $423,500 | +47.02% | |
| 2020-03-27 | Newman James W. Jr. | director | 19,644 0.1848% | $1.36 | $26,769 | +23.91% | ||
| 2020-03-26 | Stilley William B. III | Chief Executive Officer | 12,652 0.1363% | $1.47 | $18,598 | +31.54% | ||
| 2020-03-25 | Stilley William B. III | Chief Executive Officer | 12,348 0.1072% | $1.13 | $13,953 | +37.90% | ||
| 2019-12-12 | Sale | Johnson Bankole A. | Chief Medical Officer | 150,000 0.8506% | $1.00 | $150,000 | -7.44% | |
| 2019-03-29 | Johnson Bankole A. | Chief Medical Officer | 33,100 0.4057% | $3.47 | $114,801 | -50.44% | ||
| 2019-03-28 | Johnson Bankole A. | Chief Medical Officer | 40,000 0.4706% | $3.15 | $125,808 | -47.53% | ||
| 2018-07-31 | Stilley William B. III | Chief Executive Officer | 80,000 1.8029% | $5.00 | $400,000 | -28.75% | ||
| 2018-07-31 | Schuyler Kevin | director | 180,000 2.0282% | $2.50 | $450,000 | -28.75% |
| Increased Positions | 11 | +68.75% | 118,302 | +486.36% |
| Decreased Positions | 5 | -31.25% | 1,177 | -4.84% |
| New Positions | 7 | New | 110,719 | New |
| Sold Out Positions | <1 | Sold Out | 448 | Sold Out |
| Total Postitions | 22 | +37.5% | 141,449 | +481.52% |
| Geode Capital Management, Llc | $39.00 | 0.61% | 164,127 | +95,277 | +138.38% | 2025-09-30 |
| Vanguard Group Inc | $37.00 | 0.58% | 156,024 | +142,865 | +1,085.68% | 2025-09-30 |
| Citadel Advisors Llc | $34.00 | 0.53% | 143,791 | +143,791 | New | 2025-09-30 |
| Manchester Capital Management Llc | $11.00 | 0.18% | 48,097 | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $7.00 | 0.1% | 27,770 | 0 | 0% | 2025-09-30 |
| Ubs Group Ag | $4.00 | 0.07% | 18,758 | +6,363 | +51.34% | 2025-09-30 |
| Two Sigma Securities, Llc | $3.00 | 0.05% | 12,841 | +12,841 | New | 2025-09-30 |
| Jane Street Group, Llc | $3.00 | 0.05% | 12,341 | -12,521 | -50.36% | 2025-09-30 |
| Hrt Financial Lp | $3.00 | 0.04% | 11,191 | -7,899 | -41.38% | 2025-09-30 |
| Private Management Group Inc | $2.00 | 0.04% | 10,000 | +10,000 | New | 2025-09-30 |